Primary mechanisms mediating aminoglycoside resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7

Involvement of an ATP-Dependent Protease, PA0779/AsrA, in Inducing Heat Shock in Response to Tobramycin in Pseudomonas aeruginosa

(2011) Kristen N. Kindrachuk et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Sequential Mechanism of Assembly of Multidrug Efflux Pump AcrAB-TolC

(2011) Elena B. Tikhonova et al.   CHEMISTRY & BIOLOGY

The Pseudomonas aeruginosa opportunistic pathogen and human infections

(2011) Sophie de Bentzmann et al.   ENVIRONMENTAL MICROBIOLOGY

Membrane Proteases and Aminoglycoside Antibiotic Resistance

(2011) A. Hinz et al.   JOURNAL OF BACTERIOLOGY

Pseudomonas Aeruginosa: Resistance to the Max

(2011) Keith Poole   Frontiers in Microbiology

Oxidative Stress Induction of the MexXY Multidrug Efflux Genes and Promotion of Aminoglycoside Resistance Development inPseudomonas aeruginosa

(2010) Sebastien Fraud et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A Two-Component Regulatory System Interconnects Resistance to Polymyxins, Aminoglycosides, Fluoroquinolones, and β-Lactams inPseudomonas aeruginosa

(2010) Cédric Muller et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The BpeAB-OprB Efflux Pump of Burkholderia pseudomallei 1026b Does Not Play a Role in Quorum Sensing, Virulence Factor Production, or Extrusion of Aminoglycosides but Is a Broad-Spectrum Drug Efflux System

(2010) T. Mima et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Expression of Multidrug Efflux Pump GenesacrAB-tolC,mdfA, andnorEinEscherichia coliClinical Isolates as a Function of Fluoroquinolone and Multidrug Resistance

(2010) Michelle C. Swick et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pseudomonas aeruginosa bacteraemia in burns patients: Risk factors and outcomes

(2010) Patrick Mahar et al.   BURNS

Combating evolution with intelligent design: the neoglycoside ACHN-490

(2010) Eliana S Armstrong et al.   CURRENT OPINION IN MICROBIOLOGY

Multidrug Resistance among Gram-Negative Pathogens That Caused Healthcare-Associated Infections Reported to the National Healthcare Safety Network, 2006–2008

(2010) Alexander J. Kallen et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Changes in the Incidences of Multidrug-Resistant and Extensively Drug-Resistant Organisms Isolated in a Military Medical Center

(2010) Edward F. Keen et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Application of an inducible system to engineer unmarked conditional mutants of essential genes of Pseudomonas aeruginosa

(2010) Yuji Morita et al.   JOURNAL OF MICROBIOLOGICAL METHODS

Crystal structure of MexZ, a key repressor responsible for antibiotic resistance in Pseudomonas aeruginosa

(2010) Yilmaz Alguel et al.   JOURNAL OF STRUCTURAL BIOLOGY

Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study

(2010) Marie-Laurence Lambert et al.   LANCET INFECTIOUS DISEASES

Posttransplant bacteremia in adult living donor liver transplant recipients

(2010) Taku Iida et al.   LIVER TRANSPLANTATION

Complete Genome Sequence of the Multiresistant Taxonomic Outlier Pseudomonas aeruginosa PA7

(2010) Paul H. Roy et al.   PLoS One

Fmt Bypass in Pseudomonas aeruginosa Causes Induction of MexXY Efflux Pump Expression

(2009) R. E. Caughlan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efflux Unbalance in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients

(2009) L. Vettoretti et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effect of MexXY Overexpression on Ceftobiprole Susceptibility in Pseudomonas aeruginosa

(2009) E. Z. Baum et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

AAC(6')-Iaf, a Novel Aminoglycoside 6'-N-Acetyltransferase from Multidrug-Resistant Pseudomonas aeruginosa Clinical Isolates

(2009) T. Kitao et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Attributable Hospital Cost and Length of Stay Associated with Health Care-Associated Infections Caused by Antibiotic-Resistant Gram-Negative Bacteria

(2009) P. D. Mauldin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular Epidemiology of Metallo- -Lactamase-Producing Pseudomonas aeruginosa Isolates from Norway and Sweden Shows Import of International Clones and Local Clonal Expansion

(2009) O. Samuelsen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms

(2009) P. D. Lister et al.   CLINICAL MICROBIOLOGY REVIEWS

Pseudomonas aeruginosa Population Structure Revisited

(2009) Jean-Paul Pirnay et al.   PLoS One

Genome-Scale Identification Method Applied to Find Cryptic Aminoglycoside Resistance Genes in Pseudomonas aeruginosa

(2009) Julie M. Struble et al.   PLoS One

Targeting a bacterial stress response to enhance antibiotic action

(2009) S. Lee et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Relationship between Antibiotic Use and Incidence of MexXY-OprM Overproducers among Clinical Isolates of Pseudomonas aeruginosa

(2008) D. Hocquet et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Novel Genetic Determinants of Low-Level Aminoglycoside Resistance in Pseudomonas aeruginosa

(2008) K. N. Schurek et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Investigation of isolation rates of Pseudomonas aeruginosa with and without multidrug resistance in medical facilities and clinical laboratories in Japan

(2008) T. Kirikae et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY